Adjuvant chemotherapy with capecitabine plus oxaliplatin

2 trials

Sponsors

Osaka Medical Center for Cancer and Cardiovascular Diseases, Multicenter Study Group of Osaka (MCSGO), Colorectal Cancer Treatment Group

Conditions

Colon cancerColorectal cancer

Phase 2

Efficacy and Safety study of adjuvant therapy with capecitabine plus oxaliplatin (XELOX) for the Japanese patient with Stage III curative resection Colon cancer -Phase II study

Active, not recruitingJPRN-UMIN000006742

Multicenter Study Group of Osaka (MCSGO), Colorectal Cancer Treatment GroupColon cancer

Start: 2011-11-10Target: 140Updated: 2026-06-29

Unknown Phase

A feasibility study of adjuvant therapy with capecitabine plus oxaliplatin (XELOX) for the patient with advanced colorectal cancer

Active, not recruitingJPRN-UMIN000003164

Osaka Medical Center for Cancer and Cardiovascular DiseasesColorectal cancer

Start: 2010-02-01Target: 25Updated: 2026-06-29